Latest Revenue Guidance News

Page 8 of 14
Chrysos Corporation reports robust FY25 financial growth driven by global adoption of its PhotonAssay technology and secures a strategic Master Services Agreement with gold giant Newmont. The company projects further revenue and EBITDA expansion in FY26.
Maxwell Dee
Maxwell Dee
12 Aug 2025
COSOL Limited reports FY25 revenue and EBITDA below guidance due to timing delays but highlights a 17% rise in operating cash flow and maintains optimistic FY26 growth forecasts.
Sophie Babbage
Sophie Babbage
8 Aug 2025
AVITA Medical’s Q2 2025 update reveals a temporary setback in RECELL demand due to Medicare reimbursement delays, offset by strong revenue growth and promising clinical data. The company anticipates recovery and renewed growth in the second half of the year.
Ada Torres
Ada Torres
8 Aug 2025
AVITA Medical reported a 21% increase in Q2 commercial revenue to $18.4 million and narrowed its net loss, yet faces a reimbursement hurdle that forced a downward revision of full-year guidance. The company highlights clinical progress and strategic board appointments as it navigates payment challenges.
Ada Torres
Ada Torres
8 Aug 2025
Infomedia Limited has struck a deal with TPG Capital Asia to be acquired at $1.72 per share, offering shareholders a 41% premium over recent trading prices. The scheme includes fully franked dividends, potentially raising the effective value to $1.74 per share for eligible investors.
Sophie Babbage
Sophie Babbage
6 Aug 2025
MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.
Ada Torres
Ada Torres
31 July 2025
Doctor Care Anywhere has reported a landmark positive operating and investing cash inflow in Q2 2025, alongside modest consultation growth and strategic service expansion. The company reiterates its ambitious revenue and profitability targets amid ongoing cost transformation.
Ada Torres
Ada Torres
31 July 2025
Fluence Corporation reported a robust 64.7% revenue increase in the first half of 2025, driven by strong project execution in Ivory Coast and growth in key business units. Despite tariff uncertainties and a cautious China outlook, the company maintains its full-year guidance and eyes further backlog expansion.
Victor Sage
Victor Sage
31 July 2025
Fluence Corporation reports a robust 64.7% revenue increase in H1 2025, driven by strategic focus on higher-margin Smart Product Solutions and recurring revenue streams. The company maintains its FY2025 guidance, supported by a strong backlog and progress on a major Ivory Coast water project.
Victor Sage
Victor Sage
31 July 2025
Enlitic, Inc. has confirmed its commitment to achieving operational cashflow break-even by the end of 2025, alongside maintaining its revenue guidance of US$9-11 million for the calendar year.
Ada Torres
Ada Torres
31 July 2025
Appen Limited reported a mixed Q2 FY25 with a 6% revenue decline year-over-year, driven by a strong 77% surge in its China business that achieved profitability, while US market challenges persist. The company targets $10 million in cost savings to fuel future growth.
Sophie Babbage
Sophie Babbage
30 July 2025
Change Financial Limited reported a record Q4 FY25 revenue of US$4.0 million, marking a 26% year-on-year increase, alongside positive underlying EBITDA and a strong outlook for FY26.
Victor Sage
Victor Sage
29 July 2025